Dr. Samir Taneja, Consulting Editor, is stepping into the Guest Editor role for this issue of Urologic Clinics devoted to Prostate Cancer. He has assembled top experts to address the latest advances in the diagnosis and treatment of prostate cancer. Articles are devoted to the following topics: Whom to Biopsy: Pre-Diagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators; How to Biopsy: Transperineal vs. Tranrectal, Saturation vs. Targeted: What’s the Evidence; Pre-Diagnostic Risk and Assessment with Imaging and Image-guided Biopsy; Whom to treat: Post-Diagnostic Risk Assessment with Gleason score, Risk Models, and Genomic Classifier; Strategies for Staging and Utilization of Imaging; Contemporary Active Surveillance: Candidate Selection, Follow-up Tools, and Expected Outcomes; Focal Ablation of Early Stage Prostate Cancer: Candidate Selection, Treatment Guidance, and Assessment of Outcome; Extent of Lymphadenectomy at Time of Prostatectomy: An Evidence-based Approach; How to Radiate the Prostate: Hypofractionation, Sterotactic Body Radiation Therapy, and Conventional Intensity-Modulated Radiotherapy; Managing Relapse after Surgical Therapy: Adjuvant vs. Salvage Therapy; Newly diagnosed Metastatic Prostate Cancer – Has the Paradigm Changed; Role of Local therapy in Oligometastatic Prostate Cancer: Should we Expect Cure; Approaching the High-Risk Patient; and Castration-Resistant Prostate Cancer: An Algorithmic Approach. Readers will come away with state-of-the-art information on strategies for diagnosing, treating, and managing prostate cancer.
The Guest Editors of this issue of Urologic Clinics of North America have put together a comprehensive collection of articles that provides the current knowledge on urologic cancer immunotherapy.
This issue of Urologic Clinics provides the urologist with important updates to better manage patients requiring minimally invasive procedures.
In this issue of Urologic Clinics, guest editors Leonard G. Gomella and Veda Giri bring their considerable expertise to the topic of Prostate Cancer Genetics: Changing the Paradigm of Care.
Provides in-depth clinical reviews on urologic pharmacology, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field.
With guidance from Consulting Editor, Dr. Kevin Loughlin, Dr. Deepak Kapoor has created a state-of-the-art issue devoted to the future of the urologist’s clinical practice.
Huang T, Shu X, Huang YS, miscellaneous interventions for nocturnal enuresis in Database Syst Rev 2011;(12):CD005230. Cochrane etal. Complementaryand children.Cochrane Erectile Dysfunction Gretchen M. Irwin, MD, MBA KEYWORDS Erectile ...
This issue of Medical Clinics of North America, guest edited by Robert E. Brannigan, MD, is devoted to Urology.
Benign prostatic hyperplasia and the resulting lower urinary tract symptoms is a major part of almost any urologist’s clinical practice.
Elliott S, Matthew A. Sexual recovery following prostate cancer: recommendations from 2 established Canadian Sexual Rehabilitation Clinics. Sex Med Rev 2018;6(2):279–94. 56. Vroege JA, Gijs L, Hengeveld MW.
For instance, when the 2012 US Preventive Services Task Force recommended against prostatespecific antigen screening for prostate cancer, studies showed a significant decrease in prostate-specific antigen testing, prostate biopsy, ...